Versiti Acquires Fishers, Indiana-based Quantigen
Versiti has announced the acquisition of Quantigen, a specialty lab based in Fishers, Indiana. The acquisition expands Versiti’s portfolio across the drug and medical device development pathway and adds complementary expertise supporting clinical trials in infectious disease, women’s health and gastrointestinal and reproductive health. Financial terms of the deal were not disclosed. Based in Fishers, Indiana, Quantigen is a contract research organization (CRO) and a patient diagnostic laboratory whose services are focused on supporting the development of novel diagnostic tests and medical devices. Versiti is a world-class blood health organization with locations across the... Read More »
Ampersand Capital Partners Makes Growth Investment in NanoImaging Services
Ampersand Capital Partners has made a growth equity investment in NanoImaging Services, a leading provider of cryo-electron microscopy (cryo-EM) services to the pharmaceutical and biotechnology communities. Members of the NanoImaging Services management team joined Ampersand in the financing. NanoImaging Services will use this investment to support its worldwide growth initiatives, including expanding microscope capacity and adding complementary services to further serve the needs of existing and future customers. Financial terms of the deal were not disclosed. NanoImaging Services is a specialty contract research organization (CRO) that helps biopharma companies harness the power of... Read More »
EdgeCap Partners Acquires Majority Stake in Comac Medical
Funds advised by EdgeCap Partners (EdgeCap) have acquired a majority equity interest in Comac Medical. The deal was announced in a June 9 press release. Comac’s founder and CEO, Dr. Milen Vrabevski, as well as other shareholders, will retain a significant minority stake and continue in their current roles as executive managers, thereby providing continuity to all its clients and partners. Comac Medical is a full-service clinical research organization (CRO), present in more than 30 countries and providing a comprehensive range of early to late-phase drug development services to the global pharmaceutical and biotech industries across a variety of therapeutic areas. The company is... Read More »
BC Platforms Acquires 4Pharma
Paris-based BC Platforms (BCP) announced on June 1 that it acquired 4Pharma Ltd, a contract research organization (CRO). 4Pharma provides medical research services to pharmaceutical, biotechnology and medical device companies. 4Pharma was founded more than 20 years ago and has collaborations with approximately 70 clients in the Nordics, Central Europe and the US. BC Platforms is a global leader in building data networks for the life sciences industry and provides versatile technology platforms for personalized medicine, accelerating the translation of innovations into clinical practice. In November 2022, Jolt Capital invested $20 million into BC Platforms. The acquisition expands... Read More »
Syneos Health to be Acquired by a Private Investment Consortium In $7.1 Billion Deal
Syneos Health is being acquired by a consortium of private investment firm affiliates composed of Elliott Investment Management, Patient Square Capital and Veritas Capital. Completion of the transaction is expected in the second half of 2023. The consortium of private investment firm affiliates is acquiring Syneos for $43.00 per share in cash in a transaction valued at approximately $7.1 billion, including outstanding debt. The purchase price represents a 24% premium to Syneos Health’s unaffected closing stock price on February 13, 2023. Upon completion of the transaction, Syneos Health will become a private company and shares of Syneos Health Class A common stock will no longer trade on... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
